Literature DB >> 10218302

Conjunctival-limbal autografts for primary and recurrent pterygia: technique and results.

S K Rao1, T Lekha, B N Mukesh, G Sitalakshmi, P Padmanabhan.   

Abstract

Our technique of pterygium excision with conjunctival-limbal autografting is described and the safety and efficacy of the procedure in India is analysed. Case records of 51 consecutive patients (53 eyes) who underwent surgery at our institute between November 1992 and September 1994 were retrospectively analysed. Recurrence was defined as fibrovascular tissue crossing the corneoscleral limbus onto clear cornea in the area of previous pterygium excision. 2 (3.8%) of the 53 pterygia (primary 36; recurrent 17) recurred, after a mean follow up of 18.9 +/- 12.1 months (range: 1.5-43 months). Both recurrences occurred within a year of follow up, in patients who were < or = 40 years of age. No major operative or postoperative complications were encountered. The inclusion of limbal tissue in conjunctival autografts following pterygium excision appears to be essential to ensure low recurrence rates. The technique is safe, simple and inexpensive and is recommended for the management of both primary and recurrent pterygia in Indian eyes.

Entities:  

Mesh:

Year:  1998        PMID: 10218302

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  14 in total

1.  Comparison of conjunctival autograft transplantation and amniotic membrane transplantation for pterygium: a meta-analysis.

Authors:  Meiyan Li; Min Zhu; Yongfu Yu; Lan Gong; Naiqing Zhao; Mark J Robitaille
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-21       Impact factor: 3.117

2.  Comparison of mitomycin C and limbal-conjunctival autograft in the prevention of pterygial recurrence in Turkish patients: A one-year, randomized, assessor-masked, controlled trial.

Authors:  Seyhmus Ari; Ihsan Caca; Zennure Özdemir Yildiz; Yildirim Bayezit Sakalar; Eyüp Dogan
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

3.  Conjunctival autograft in primary and recurrent pterygium: a study.

Authors:  Kavita Mallikarjun Salagar; Kalyanappa Gurlingappa Biradar
Journal:  J Clin Diagn Res       Date:  2013-12-15

4.  Conjunctival-Limbal Autograft for Primary and Recurrent Pterygium.

Authors:  K N Jha
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision.

Authors:  P Luanratanakorn; T Ratanapakorn; O Suwan-Apichon; R S Chuck
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

6.  Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial.

Authors:  Rongxin Chen; Guofu Huang; Shu Liu; Wenfang Ma; Xiaofang Yin; Shiyou Zhou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-20       Impact factor: 3.117

7.  Safety profile and complications of autologous limbal conjunctival transplantation for primary pterygium.

Authors:  Srinivasapuram Krishnachary Prabhakar
Journal:  Saudi J Ophthalmol       Date:  2014-03-21

8.  A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium.

Authors:  A L Young; G Y S Leung; A K K Wong; L L Cheng; D S C Lam
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

9.  Comparison of limbal-conjunctival autograft and intraoperative 0.02% mitomycin-C for treatment of primary pterygium.

Authors:  Arsen Akinci; Orhan Zilelioglu
Journal:  Int Ophthalmol       Date:  2007-08-08       Impact factor: 2.031

10.  Fifteen-year results of a randomized controlled trial comparing 0.02% mitomycin C, limbal conjunctival autograft, and combined mitomycin C with limbal conjunctival autograft in recurrent pterygium surgery.

Authors:  Ka Wai Kam; Alvin L Young
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-24       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.